Literature DB >> 30534641

Screening for Humoral Immunodeficiency in Patients with Community-Acquired Pneumonia.

Karthik Vadamalai1, Denise Sanche-Tejera1, Jonathan Bress1,2, S Shahzad Mustafa1,3.   

Abstract

BACKGROUND: Immunodeficiency is an underrecognized risk factor for infections, such as community-acquired pneumonia (CAP).
OBJECTIVE: We evaluated patients admitted with CAP for humoral immunodeficiency.
DESIGN: Prospective Cohort Study.
SETTING: Inpatients. PATIENTS, INTERVENTION, AND MEASUREMENTS: We enrolled 100 consecutive patients admitted with a diagnosis of CAP from February 2017 to April 2017. Serum IgG, IgM, IgA, and IgE levels were obtained within the first 24 hours of admission. CURB-65 score and length of hospital stay were calculated. The Wilcoxon rank-sum test, Kruskal-Wallis test, and simple linear regression analysis were used in data analysis.
RESULTS: The prevalence of hypogammaglobinemia in patients with CAP was 38% (95% confidence interval: 28.47% to 48.25%). Twenty-seven of 100 patients had IgG hypogammaglobinemia (median: 598 mg/dL, IQ range: 459-654), 23 of 100 had IgM hypogammaglobinemia (median: 38 mg/dL, IQ range: 25-43), and 6 of 100 had IgA hypogammaglobinemia (median: 36 mg/dL, IQ range: 18-50). The median hospital length of stay for patients with IgG hypogammaglobinemia was significantly higher when compared to patients with normal IgG levels (five days, IQ range [3-10] vs three days, IQ range [2-5], P = .0085). Fourteen patients underwent further immune evaluation, resulting in one diagnosis of multiple myeloma, three patients diagnosed with specific antibody deficiency, and one patient diagnosed with selective IgA deficiency.
CONCLUSION: There is a high prevalence of hypogammaglobinemia in patients hospitalized with CAP, with IgG and IgM being the most commonly affected classes. IgG hypogammaglobinemia was associated with an increased length of hospitalization. Screening immunoglobulin levels in CAP patients may also uncover underlying humoral immunodeficiency or immunoproliferative disorders.
© 2018 Society of Hospital Medicine.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30534641     DOI: 10.12788/jhm.3106

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  2 in total

Review 1.  Schizophrenia and COVID-19: risks and recommendations.

Authors:  Lais Fonseca; Elton Diniz; Guilherme Mendonça; Fernando Malinowski; Jair Mari; Ary Gadelha
Journal:  Braz J Psychiatry       Date:  2020-04-09       Impact factor: 2.697

2.  Aging and therapy-related hypogammaglobulinemia causing pneumonia: An overlooked curable entity in the chaotic COVID-19 pandemic.

Authors:  Syed Ziauddin Ahmed Zaidi; Fatima Zia Zaidi; Nawal AlShehry; Abdul Rehman Zia Zaidi; Saleha Zia Zaidi; Syed Maaz Abdullah
Journal:  J Med Virol       Date:  2020-07-28       Impact factor: 20.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.